217 reports of this reaction
3.4% of all CEFADROXIL reports
#5 most reported adverse reaction
VOMITING is the #5 most commonly reported adverse reaction for CEFADROXIL, manufactured by Aurobindo Pharma Limited. There are 217 FDA adverse event reports linking CEFADROXIL to VOMITING. This represents approximately 3.4% of all 6,348 adverse event reports for this drug.
Patients taking CEFADROXIL who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is moderately reported among CEFADROXIL users, representing a notable but not dominant share of adverse events.
In addition to vomiting, the following adverse reactions have been reported for CEFADROXIL:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 217 FDA reports for CEFADROXIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 3.4% of all adverse event reports for CEFADROXIL, making it a notable side effect.
If you experience vomiting while taking CEFADROXIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.